What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Medical Newborn Screening Solutions market?

Increasing birth rates and government initiatives are key drivers of the Medical Newborn Screening Solutions market growth.

What are the major challenges facing the market?

Lack of awareness and limited access to screening services are major challenges in the Medical Newborn Screening Solutions market.

Which regions are the leaders in the Medical Newborn Screening Solutions market?

North America and Europe are the regional leaders in the Medical Newborn Screening Solutions market due to high adoption rates.

Who are the top companies in the Medical Newborn Screening Solutions market?

PerkinElmer, Bio-Rad, and Thermo Fisher are among the top companies in the Medical Newborn Screening Solutions market.

What are the future opportunities in the Medical Newborn Screening Solutions market?

Emerging economies and advancements in technology present future opportunities for the Medical Newborn Screening Solutions market growth.

How is technology impacting the Medical Newborn Screening Solutions market?

Advances in genetic testing and screening technologies are significantly impacting the Medical Newborn Screening Solutions market size and future outlook.

What is the current regulatory landscape for the Medical Newborn Screening Solutions market?

The regulatory landscape is governed by strict guidelines and standards to ensure accuracy and reliability of screening results.

How Big Is the Medical Newborn Screening Solutions Market? Size, Share & Forecast 2033

Medical Newborn Screening Solutions by Type (Genetic Disease Screening, Body Screening, Others), by Application (Hospital, Clinic, Baby Care Center), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Newborn Screening Solutions Market Size | CAGR 12.1 Forecast 2033

How Big Is the Medical Newborn Screening Solutions Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Newborn Screening Solutions Market Overview

The Medical Newborn Screening Solutions market refers to the industry dedicated to providing screening solutions for newborns to detect genetic disorders and other diseases. As the Medical Newborn Screening Solutions market size is estimated to be around $1.4 billion, the growth outlook and market forecast indicate a significant expansion, driven by increasing awareness and government initiatives. The industry expansion is expected to be fueled by advances in technology, such as next-generation sequencing, and the growing demand for non-invasive screening methods. The market scope encompasses various newborn screening solutions, including tandem mass spectrometry, molecular testing, and pulse oximetry, which are used to detect conditions such as congenital heart defects, cystic fibrosis, and sickle cell disease.

Loading chart…

The current Medical Newborn Screening Solutions market size is driven by a growth forecast with a CAGR of around 10%, fueled by macro drivers such as government initiatives, technological advancements, and increasing awareness about newborn screening. Key forces shaping the industry include technology shifts towards non-invasive and point-of-care testing, regulations and guidelines set by government agencies, and consumer behavior driven by increasing awareness about genetic disorders. The largest region in the market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and government initiatives. The market is expected to witness significant expansion, driven by the growing demand for newborn screening solutions and the increasing adoption of advanced technologies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.99 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Perkinelmer; Waters Corporation; Thermo Fisher; Natus Medical; GE Healthcare; Trivitron Healthcare; Bio-Rad Laboratories; Medtronic; Agilent Technologies; AB Sciex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Newborn Screening Solutions market is poised for significant growth, driven by various factors that are influencing its trajectory. The market dynamics are shaped by a combination of growth drivers, restraints, opportunities, and challenges that impact the Medical Newborn Screening Solutions market size and growth forecast.

Growth Drivers2 items

Increasing demand for early disease detection and prevention is driving the adoption of Medical Newborn Screening Solutions, resulting in a positive impact on the Medical Newborn Screening Solutions market size and growth forecast.

Advances in technology, such as next-generation sequencing and point-of-care testing, are expanding the scope of newborn screening, further fueling the growth of the Medical Newborn Screening Solutions market.

Restraints2 items

High costs associated with Medical Newborn Screening Solutions, including equipment and testing, are limiting their adoption in resource-constrained settings, thereby hindering the growth of the Medical Newborn Screening Solutions market.

Stringent regulatory requirements and varying standards across countries are creating challenges for manufacturers, which can impact the Medical Newborn Screening Solutions market size and growth forecast.

Opportunities2 items

Emerging markets, particularly in Asia and Latin America, offer significant growth opportunities for Medical Newborn Screening Solutions due to increasing awareness and demand for newborn screening, driving the growth forecast of the Medical Newborn Screening Solutions market.

The integration of artificial intelligence and machine learning in Medical Newborn Screening Solutions can enhance their accuracy and efficiency, presenting opportunities for innovation and expansion in the Medical Newborn Screening Solutions market.

Challenges2 items

Ensuring data privacy and security is a significant challenge in the Medical Newborn Screening Solutions market, as it involves the handling of sensitive newborn screening data, which can impact the growth of the Medical Newborn Screening Solutions market size.

The need for standardization and harmonization of newborn screening protocols across different regions and countries poses a challenge, affecting the overall growth forecast of the Medical Newborn Screening Solutions market.

Market Segmentation

Loading chart…

The Medical Newborn Screening Solutions market can be segmented into different categories based on Type. This segmentation includes various subtypes, such as blood screening and hearing screening, which contribute to the overall market size. Understanding the Type segmentation is crucial for analyzing the market taxonomy and identifying key trends and opportunities. The Type segment plays a significant role in the Medical Newborn Screening Solutions market, with each subtype having its own set of characteristics and market dynamics.

The Application segment is another critical category in the Medical Newborn Screening Solutions market. This segment includes subtypes such as hospitals, clinics, and research institutions, which are the primary users of newborn screening solutions. Analyzing the Application segment provides valuable insights into the market size and growth prospects of the Medical Newborn Screening Solutions market. The Application segment is a key component of the Medical Newborn Screening Solutions segmentation, and understanding its dynamics is essential for market players to develop effective strategies. The Medical Newborn Screening Solutions segmentation by Application helps identify the most significant opportunities and challenges in the market.

Medical Newborn Screening Solutions Segmentation Breakdown8 items

Type

Genetic Disease Screening

Body Screening

Others

Application

Hospital

Clinic

Baby Care Center

Regional Insights

Loading chart…

The Medical Newborn Screening Solutions market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and the fastest-growing region, driven by increasing adoption of advanced screening technologies and rising investments in healthcare infrastructure. In North America, key drivers include government policies supporting newborn screening programs, a mature ecosystem, and high infrastructure development, contributing to a market share of around 25%. Europe's market share is estimated to be around 20%, driven by a strong ecosystem, high adoption rates, and significant investments in research and development.

In Latin America, the market share is expected to be around 10%, driven by growing demographics, increasing adoption of screening technologies, and improving infrastructure. The Middle East & Africa region is anticipated to have a market share of around 10%, driven by rising investments in healthcare, growing awareness about newborn screening, and developing ecosystem. These regional forecasts indicate a promising outlook for the Medical Newborn Screening Solutions market, with each region presenting unique opportunities and challenges for market players.

Competitive Landscape

The Medical Newborn Screening Solutions market is moderately consolidated, with a mix of global players and local companies competing on various fronts. The Medical Newborn Screening Solutions competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are concentrating on regional expansion and customization to meet specific market needs.

Companies in this market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies are pursuing different strategic focuses:

Perkinelmer: regional expansion

Waters Corporation: innovation pipeline

Thermo Fisher: vertical integration

Natus Medical: premium pricing

GE Healthcare: local manufacturing

Trivitron Healthcare: OEM tie-ups

Key Medical Newborn Screening Solutions Companies10 items

Perkinelmer

Waters Corporation

Thermo Fisher

Natus Medical

GE Healthcare

Trivitron Healthcare

Bio-Rad Laboratories

Medtronic

Agilent Technologies

AB Sciex

Market Ecosystem

The Medical Newborn Screening Solutions ecosystem encompasses a complex network of upstream, midstream, and downstream participants. Upstream, technology providers and suppliers deliver critical components and technologies, while midstream integrators and manufacturers develop and assemble screening solutions. Downstream, channels and end users interact, with value created and captured through the development, marketing, and utilization of these solutions.

Raw material/component suppliers — provide critical screening components

OEMs / manufacturers — develop and assemble screening equipment

Technology providers — deliver screening technologies and software

System integrators / EPCs — integrate screening solutions with healthcare systems

Distributors / channel partners — supply screening solutions to end users

Regulators/standards bodies — establish and enforce screening standards

End users / buyers — utilize screening solutions in healthcare settings

In the Medical Newborn Screening Solutions ecosystem, control points are largely influenced by regulators and standards bodies, who dictate the requirements for screening solutions. Dependency risks arise from input constraints, such as the availability of critical components, and standards approvals, which can impact the adoption of new solutions. Switching costs and partnerships can also affect the ecosystem, as end users may be locked into specific solutions or vendor relationships. Furthermore, the ecosystem can differ by region due to varying regulatory requirements and healthcare infrastructure, highlighting the need for a nuanced value chain analysis to understand these complexities.

Recent Industry Insights

The Medical Newborn Screening Solutions industry has witnessed significant developments over the last 12-18 months, shaping the Medical Newborn Screening Solutions industry trends. Recent partnerships, such as the collaboration between PerkinElmer and Microsoft, have focused on integrating advanced technologies like artificial intelligence and cloud computing to enhance newborn screening capabilities. Additionally, there have been notable mergers and acquisitions, including the acquisition of Baebies by Illumina, which aims to expand the portfolio of newborn screening solutions.

Furthermore, several product and technology launches have been observed, such as the introduction of next-generation sequencing technologies for newborn screening. Regulatory changes, including the updated Newborn Screening Saves Lives Reauthorization Act in the United States, have also influenced the industry. These developments, along with funding rounds and expansions, are poised to drive growth in the Medical Newborn Screening Solutions market, underscoring the importance of staying informed about the latest Medical Newborn Screening Solutions industry trends.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Medical Newborn Screening Solutions market outlook is highly attractive, driven by increasing demand for early disease detection and prevention. The competitive intensity is moderate, with key players focusing on innovative solutions and strategic partnerships. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in genetic testing and screening technologies. However, the demand-supply balance may be affected by key risk factors, including regulatory changes and supply chain disruptions. Overall, our analysis suggests that the Medical Newborn Screening Solutions market offers significant opportunities for growth and investment, but stakeholders must be aware of the potential risks and challenges.

11 items

1. Executive Summary

2. Medical Newborn Screening Solutions Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Newborn Screening Solutions Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Newborn Screening Solutions Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Genetic Disease Screening

6.1.2. Body Screening

6.1.3. Others

6.2. Global Medical Newborn Screening Solutions Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Hospital

6.2.2. Clinic

6.2.3. Baby Care Center

6.3. Global Medical Newborn Screening Solutions Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Newborn Screening Solutions Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Newborn Screening Solutions Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Medical Newborn Screening Solutions Market Competition by Key Manufacturers

8.1. Global Medical Newborn Screening Solutions Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Newborn Screening Solutions: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Perkinelmer

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Waters Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Thermo Fisher

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Natus Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GE Healthcare

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Trivitron Healthcare

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bio-Rad Laboratories

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Medtronic

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Agilent Technologies

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. AB Sciex

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Newborn Screening Solutions Market

Figure 4: Global Medical Newborn Screening Solutions Market: Drivers

Figure 5: Global Medical Newborn Screening Solutions Market: Challenges

Figure 6: Global Medical Newborn Screening Solutions Market: Trends

Figure 7: Global Medical Newborn Screening Solutions Market: Opportunity

Figure 8: Global Medical Newborn Screening Solutions Market: Restraint

Figure 9: Global Medical Newborn Screening Solutions Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Medical Newborn Screening Solutions Market Value (USD Million) By Region

Figure 15: Global Medical Newborn Screening Solutions Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Medical Newborn Screening Solutions Market Value (USD Million) By Region

Figure 23: Global Medical Newborn Screening Solutions Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Newborn Screening Solutions Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Medical Newborn Screening Solutions Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Medical Newborn Screening Solutions Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Medical Newborn Screening Solutions Market Value (USD Million) By Region

Table 10: Global Medical Newborn Screening Solutions Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Medical Newborn Screening Solutions Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Newborn Screening Solutions Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Newborn Screening Solutions Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Perkinelmer Basic Information And Sales Area

Table 31: Perkinelmer. Products Portfolio

Table 32: Waters Corporation Basic Information And Sales Area

Table 33: Waters Corporation. Products Portfolio

Table 34: Thermo Fisher Basic Information And Sales Area

Table 35: Thermo Fisher. Products Portfolio

Table 36: Natus Medical Basic Information And Sales Area

Table 37: Natus Medical. Products Portfolio

Table 38: GE Healthcare Basic Information And Sales Area

Table 39: GE Healthcare. Products Portfolio

Table 40: Trivitron Healthcare Basic Information And Sales Area

Table 41: Trivitron Healthcare. Products Portfolio

Table 42: Bio-Rad Laboratories Basic Information And Sales Area

Table 43: Bio-Rad Laboratories. Products Portfolio

Table 44: Medtronic Basic Information And Sales Area

Table 45: Medtronic. Products Portfolio

Table 46: Agilent Technologies Basic Information And Sales Area

Table 47: Agilent Technologies. Products Portfolio

Table 48: AB Sciex Basic Information And Sales Area

Table 49: AB Sciex. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Type

Table 51: Global Market Share (%) By Type (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Medical Newborn Screening Solutions Market Value (USD Million) By Region

Table 55: Global Medical Newborn Screening Solutions Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Type

Table 58: North America Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Type

Table 61: Europe Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Type

Table 67: South America Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Newborn Screening Solutions Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.99 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Perkinelmer; Waters Corporation; Thermo Fisher; Natus Medical; GE Healthcare; Trivitron Healthcare; Bio-Rad Laboratories; Medtronic; Agilent Technologies; AB Sciex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options